Long‐term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection

Patients with pure teratoma within the postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND) specimen traditionally have been considered at low risk for disease progression. The objectives of this study were to determine the disease‐related outcomes of patients who had pure teratoma identified at the time of PC‐RPLND and to examine the prognostic value of clinical variables that were identified previously as important predictors of disease recurrence in these patients.